VERICEL CORPORATION Research and Development Expense
VERICEL CORPORATION (VCEL) reported Research and Development Expense of $7.49 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-30
- VERICEL CORPORATION research and development expense for the quarter ending 2026-06-30 was $7.49M, a 11.32% increase year-over-year.
- VERICEL CORPORATION research and development expense for the quarter ending 2026-03-31 was $8.10M, a 11.61% increase year-over-year.
- VERICEL CORPORATION research and development expense for the quarter ending 2025-12-31 was $7.25M, a 47.33% increase year-over-year.
- VERICEL CORPORATION research and development expense for the quarter ending 2025-09-30 was $6.32M, a 3.69% increase year-over-year.
- VERICEL CORPORATION research and development expense for fiscal 2025 was $27.56M, a 11.15% increase from fiscal 2024.
- VERICEL CORPORATION research and development expense for fiscal 2024 was $24.80M, a 17.85% increase from fiscal 2023.
- VERICEL CORPORATION research and development expense for fiscal 2023 was $21.04M, a 5.51% increase from fiscal 2022.
- VERICEL CORPORATION research and development expense for fiscal 2022 was $19.94M, a 22.45% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 267 month | Research and Development Expense 270 month | Research and Development Expense 273 month | Research and Development Expense 276 month | Research and Development Expense 279 month | Research and Development Expense 282 month | Research and Development Expense 285 month | Research and Development Expense 288 month | Research and Development Expense 291 month | Research and Development Expense 294 month | Research and Development Expense 297 month | Research and Development Expense 300 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.49M 10-Q · filed 2026-07-30 | $15.60M 10-Q · filed 2026-07-30 | $22.85M derived: sum of 3 quarters · filed 2026-07-30 | $29.17M derived: sum of 4 quarters · filed 2026-07-30 | ||||||||||||
| 2026-03-31 | $8.10M 10-Q · filed 2026-05-07 | $15.36M derived: sum of 2 quarters · filed 2026-05-07 | $21.68M derived: sum of 3 quarters · filed 2026-05-07 | $28.41M derived: sum of 4 quarters · filed 2026-07-30 | ||||||||||||
| 2025-12-31 | $7.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $13.57M derived: sum of 2 quarters · filed 2026-02-26 | $20.30M derived: sum of 3 quarters · filed 2026-07-30 | $27.56M 10-K · filed 2026-02-26 | ||||||||||||
| 2025-09-30 | $6.32M 10-Q · filed 2025-11-06 | $13.05M derived: sum of 2 quarters · filed 2026-07-30 | $20.31M 10-Q · filed 2025-11-06 | $25.23M derived: sum of 4 quarters · filed 2026-07-30 | ||||||||||||
| 2025-06-30 | $6.73M 10-Q · filed 2026-07-30 | $13.99M 10-Q · filed 2026-07-30 | $18.91M derived: sum of 3 quarters · filed 2026-07-30 | $25.01M derived: sum of 4 quarters · filed 2026-07-30 | ||||||||||||
| 2025-03-31 | $7.26M 10-Q · filed 2026-05-07 | $12.18M derived: sum of 2 quarters · filed 2026-05-07 | $18.28M derived: sum of 3 quarters · filed 2026-05-07 | $25.64M derived: sum of 4 quarters · filed 2026-05-07 | ||||||||||||
| 2024-12-31 | $4.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.02M derived: sum of 2 quarters · filed 2026-02-26 | $18.38M derived: sum of 3 quarters · filed 2026-02-26 | $24.80M 10-K · filed 2026-02-26 | ||||||||||||
| 2024-09-30 | $6.09M 10-Q · filed 2025-11-06 | $13.46M derived: sum of 2 quarters · filed 2025-11-06 | $19.87M 10-Q · filed 2025-11-06 | $24.77M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||
| 2024-06-30 | $7.36M 10-Q · filed 2025-07-31 | $13.78M 10-Q · filed 2025-07-31 | $18.68M derived: sum of 3 quarters · filed 2026-02-26 | $24.36M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||
| 2024-03-31 | $6.42M 10-Q · filed 2025-05-08 | $11.32M derived: sum of 2 quarters · filed 2026-02-26 | $17.00M derived: sum of 3 quarters · filed 2026-02-26 | $22.25M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||
| 2023-12-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.58M derived: sum of 2 quarters · filed 2026-02-26 | $15.83M derived: sum of 3 quarters · filed 2026-02-26 | $21.04M 10-K · filed 2026-02-26 | ||||||||||||
| 2023-09-30 | $5.68M 10-Q · filed 2024-11-07 | $10.93M derived: sum of 2 quarters · filed 2024-11-07 | $16.14M 10-Q · filed 2024-11-07 | $21.39M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||
| 2023-06-30 | $5.25M 10-Q · filed 2024-08-01 | $10.46M 10-Q · filed 2024-08-01 | $15.71M derived: sum of 3 quarters · filed 2025-02-27 | $20.76M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||
| 2023-03-31 | $5.21M 10-Q · filed 2024-05-08 | $10.46M derived: sum of 2 quarters · filed 2025-02-27 | $15.50M derived: sum of 3 quarters · filed 2025-02-27 | $20.30M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||
| 2022-12-31 | $5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $10.29M derived: sum of 2 quarters · filed 2025-02-27 | $15.08M derived: sum of 3 quarters · filed 2025-02-27 | $19.94M 10-K · filed 2025-02-27 | ||||||||||||
| 2022-09-30 | $5.05M 10-Q · filed 2023-11-08 | $9.84M derived: sum of 2 quarters · filed 2023-11-08 | $14.70M 10-Q · filed 2023-11-08 | $18.62M derived: sum of 4 quarters · filed 2024-02-29 | ||||||||||||
| 2022-06-30 | $4.79M 10-Q · filed 2023-08-02 | $9.65M 10-Q · filed 2023-08-02 | $13.58M derived: sum of 3 quarters · filed 2024-02-29 | $17.86M derived: sum of 4 quarters · filed 2024-02-29 | ||||||||||||
| 2022-03-31 | $4.86M 10-Q · filed 2023-05-10 | $8.78M derived: sum of 2 quarters · filed 2024-02-29 | $13.07M derived: sum of 3 quarters · filed 2024-02-29 | $17.52M derived: sum of 4 quarters · filed 2024-02-29 | ||||||||||||
| 2021-12-31 | $3.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $8.21M derived: sum of 2 quarters · filed 2024-02-29 | $12.66M derived: sum of 3 quarters · filed 2024-02-29 | $16.29M 10-K · filed 2024-02-29 | ||||||||||||
| 2021-09-30 | $4.28M 10-Q · filed 2022-11-09 | $8.73M derived: sum of 2 quarters · filed 2022-11-09 | $12.36M 10-Q · filed 2022-11-09 | $15.48M derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||
| 2021-06-30 | $4.45M 10-Q · filed 2022-08-03 | $8.08M 10-Q · filed 2022-08-03 | $11.20M derived: sum of 3 quarters · filed 2023-02-23 | $14.11M derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||
| 2021-03-31 | $3.63M 10-Q · filed 2022-05-04 | $6.75M derived: sum of 2 quarters · filed 2023-02-23 | $9.66M derived: sum of 3 quarters · filed 2023-02-23 | $12.89M derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||
| 2020-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $6.03M derived: sum of 2 quarters · filed 2023-02-23 | $9.26M derived: sum of 3 quarters · filed 2023-02-23 | $13.02M 10-K · filed 2023-02-23 | ||||||||||||
| 2020-09-30 | $2.91M 10-Q · filed 2021-11-09 | $6.14M derived: sum of 2 quarters · filed 2021-11-09 | $9.90M 10-Q · filed 2021-11-09 | $13.12M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||||||
| 2020-06-30 | $3.23M 10-Q · filed 2021-08-04 | $6.99M 10-Q · filed 2021-08-04 | $10.21M derived: sum of 3 quarters · filed 2022-02-24 | $13.30M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||||||
| 2020-03-31 | $3.76M 10-Q · filed 2021-05-05 | $6.98M derived: sum of 2 quarters · filed 2022-02-24 | $10.08M derived: sum of 3 quarters · filed 2022-02-24 | $31.15M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||||||
| 2019-12-31 | $3.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $6.31M derived: sum of 2 quarters · filed 2022-02-24 | $27.38M derived: sum of 3 quarters · filed 2022-02-24 | $30.39M 10-K · filed 2022-02-24 | ||||||||||||
| 2019-09-30 | $3.10M 10-Q · filed 2020-11-05 | $24.17M derived: sum of 2 quarters · filed 2020-11-05 | $27.17M 10-Q · filed 2020-11-05 | $30.19M derived: sum of 4 quarters · filed 2021-02-24 | ||||||||||||
| 2019-06-30 | $21.07M 10-Q · filed 2020-08-05 | $24.08M 10-Q · filed 2020-08-05 | $27.10M derived: sum of 3 quarters · filed 2021-02-24 | $30.21M derived: sum of 4 quarters · filed 2021-02-24 | ||||||||||||
| 2019-03-31 | $3.01M 10-Q · filed 2020-05-11 | $6.03M derived: sum of 2 quarters · filed 2021-02-24 | $9.14M derived: sum of 3 quarters · filed 2021-02-24 | $12.88M derived: sum of 4 quarters · filed 2021-02-24 | ||||||||||||
| 2018-12-31 | $3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $6.13M derived: sum of 2 quarters · filed 2021-02-24 | $9.87M derived: sum of 3 quarters · filed 2021-02-24 | $13.60M 10-K · filed 2021-02-24 | ||||||||||||
| 2018-09-30 | $3.11M 10-Q · filed 2019-11-05 | $6.85M derived: sum of 2 quarters · filed 2019-11-05 | $10.58M 10-Q · filed 2019-11-05 | $14.17M derived: sum of 4 quarters · filed 2020-02-25 | ||||||||||||
| 2018-06-30 | $3.74M 10-Q · filed 2019-08-06 | $7.47M 10-Q · filed 2019-08-06 | $11.05M derived: sum of 3 quarters · filed 2020-02-25 | $13.97M derived: sum of 4 quarters · filed 2020-02-25 | ||||||||||||
| 2018-03-31 | $3.73M 10-Q · filed 2019-05-07 | $7.32M derived: sum of 2 quarters · filed 2020-02-25 | $10.23M derived: sum of 3 quarters · filed 2020-02-25 | $13.21M derived: sum of 4 quarters · filed 2020-02-25 | ||||||||||||
| 2017-12-31 | $3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $6.51M derived: sum of 2 quarters · filed 2020-02-25 | $9.48M derived: sum of 3 quarters · filed 2020-02-25 | $12.94M 10-K · filed 2020-02-25 | ||||||||||||
| 2017-09-30 | $2.92M 10-Q · filed 2018-11-06 | $5.89M derived: sum of 2 quarters · filed 2018-11-06 | $9.36M 10-Q · filed 2018-11-06 | $13.62M derived: sum of 4 quarters · filed 2019-02-26 | ||||||||||||
| 2017-06-30 | $2.97M 10-Q · filed 2018-08-06 | $6.44M 10-Q · filed 2018-08-06 | $10.70M derived: sum of 3 quarters · filed 2019-02-26 | $14.14M derived: sum of 4 quarters · filed 2019-02-26 | ||||||||||||
| 2017-03-31 | $3.47M 10-Q · filed 2018-05-08 | $7.72M derived: sum of 2 quarters · filed 2019-02-26 | $11.17M derived: sum of 3 quarters · filed 2019-02-26 | $15.23M derived: sum of 4 quarters · filed 2019-02-26 | ||||||||||||
| 2016-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $7.70M derived: sum of 2 quarters · filed 2019-02-26 | $11.76M derived: sum of 3 quarters · filed 2019-02-26 | $15.29M 10-K · filed 2019-02-26 | ||||||||||||
| 2016-09-30 | $3.44M 10-Q · filed 2017-11-07 | $7.50M derived: sum of 2 quarters · filed 2017-11-07 | $11.04M 10-Q · filed 2017-11-07 | $18.44M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||||
| 2016-06-30 | $4.06M 10-Q · filed 2017-08-09 | $7.59M 10-Q · filed 2017-08-09 | $15.00M derived: sum of 3 quarters · filed 2018-03-05 | $18.74M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||||
| 2016-03-31 | $3.54M 10-Q · filed 2017-05-10 | $10.94M derived: sum of 2 quarters · filed 2018-03-05 | $14.68M derived: sum of 3 quarters · filed 2018-03-05 | $18.05M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||||
| 2015-12-31 | $7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $11.14M derived: sum of 2 quarters · filed 2018-03-05 | $14.51M derived: sum of 3 quarters · filed 2018-03-05 | $18.89M 10-K · filed 2018-03-05 | ||||||||||||
| 2015-09-30 | $3.74M 10-Q · filed 2016-11-07 | $7.11M derived: sum of 2 quarters · filed 2016-11-07 | $11.49M 10-Q · filed 2016-11-07 | $17.28M derived: sum of 4 quarters · filed 2017-03-13 | ||||||||||||
| 2015-06-30 | $3.37M 10-Q · filed 2016-08-08 | $7.75M 10-Q · filed 2016-08-08 | $13.54M derived: sum of 3 quarters · filed 2017-03-13 | $21.37M derived: sum of 4 quarters · filed 2017-03-13 | ||||||||||||
| 2015-03-31 | $4.38M 10-Q · filed 2016-05-10 | $10.17M derived: sum of 2 quarters · filed 2017-03-13 | $18.00M derived: sum of 3 quarters · filed 2017-03-13 | $22.37M derived: sum of 4 quarters · filed 2017-03-13 | ||||||||||||
| 2014-12-31 | $5.79M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $13.63M derived: sum of 2 quarters · filed 2017-03-13 | $17.99M derived: sum of 3 quarters · filed 2017-03-13 | $21.26M 10-K · filed 2017-03-13 | ||||||||||||
| 2014-09-30 | $7.83M 10-Q · filed 2015-11-13 | $12.20M derived: sum of 2 quarters · filed 2015-11-13 | $15.47M 10-Q · filed 2015-11-13 | $18.79M derived: sum of 4 quarters · filed 2016-03-14 | ||||||||||||
| 2014-06-30 | $4.36M 10-Q · filed 2015-08-12 | $7.63M 10-Q · filed 2015-08-12 | $10.95M derived: sum of 3 quarters · filed 2016-03-14 | $13.53M derived: sum of 4 quarters · filed 2016-03-14 | ||||||||||||
| 2014-03-31 | $3.27M 10-Q · filed 2015-05-14 | $6.59M derived: sum of 2 quarters · filed 2016-03-14 | $9.16M derived: sum of 3 quarters · filed 2016-03-14 | $12.84M derived: sum of 4 quarters · filed 2016-03-14 | $235.10M 10-Q · filed 2014-05-15 | |||||||||||
| 2013-12-31 | $3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $5.89M derived: sum of 2 quarters · filed 2016-03-14 | $9.57M derived: sum of 3 quarters · filed 2016-03-14 | $15.10M 10-K · filed 2016-03-14 | $231.83M 10-K · filed 2014-03-13 | |||||||||||
| 2013-09-30 | $2.58M 10-Q · filed 2014-11-13 | $6.25M derived: sum of 2 quarters · filed 2014-11-13 | $11.79M 10-Q · filed 2014-11-13 | $17.80M derived: sum of 4 quarters · filed 2015-03-25 | $228.52M 10-Q · filed 2013-11-12 | |||||||||||
| 2013-06-30 | $3.68M 10-Q · filed 2014-08-14 | $9.21M 10-Q · filed 2014-08-14 | $15.23M derived: sum of 3 quarters · filed 2015-03-25 | $21.37M derived: sum of 4 quarters · filed 2015-03-25 | $225.94M 10-Q · filed 2013-08-07 | |||||||||||
| 2013-03-31 | $5.54M 10-Q · filed 2014-05-15 | $11.55M derived: sum of 2 quarters · filed 2015-03-25 | $17.70M derived: sum of 3 quarters · filed 2015-03-25 | $24.77M derived: sum of 4 quarters · filed 2015-03-25 | $222.27M 10-Q · filed 2013-05-08 | |||||||||||
| 2012-12-31 | $6.01M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | $12.16M derived: sum of 2 quarters · filed 2015-03-25 | $19.23M derived: sum of 3 quarters · filed 2015-03-25 | $26.02M 10-K · filed 2015-03-25 | $216.73M 10-K · filed 2013-03-18 | |||||||||||
| 2012-09-30 | $6.15M 10-Q · filed 2013-11-12 | $13.22M derived: sum of 2 quarters · filed 2013-11-12 | $20.01M 10-Q · filed 2013-11-12 | $25.92M derived: sum of 4 quarters · filed 2014-03-13 | $210.72M 10-Q · filed 2012-11-08 | |||||||||||
| 2012-06-30 | $7.07M 10-Q · filed 2013-08-07 | $13.87M 10-Q · filed 2013-08-07 | $19.77M derived: sum of 3 quarters · filed 2014-03-13 | $25.52M derived: sum of 4 quarters · filed 2014-03-13 | $204.57M 10-Q · filed 2012-08-07 | |||||||||||
| 2012-03-31 | $6.80M 10-Q · filed 2013-05-08 | $12.70M derived: sum of 2 quarters · filed 2014-03-13 | $18.45M derived: sum of 3 quarters · filed 2014-03-13 | $23.75M derived: sum of 4 quarters · filed 2014-03-13 | $197.50M 10-Q · filed 2012-05-10 | |||||||||||
| 2011-12-31 | $5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $11.65M derived: sum of 2 quarters · filed 2014-03-13 | $16.96M derived: sum of 3 quarters · filed 2014-03-13 | $21.33M 10-K · filed 2014-03-13 | $190.71M 10-K · filed 2012-03-15 | |||||||||||
| 2011-09-30 | $5.75M 10-Q · filed 2012-11-08 | $11.05M derived: sum of 2 quarters · filed 2012-11-08 | $15.43M 10-Q · filed 2012-11-08 | $19.87M derived: sum of 4 quarters · filed 2013-03-18 | $184.80M 10-Q · filed 2011-11-08 | |||||||||||
| 2011-06-30 | $5.30M 10-Q · filed 2012-08-07 | $9.68M 10-Q · filed 2012-08-07 | $14.12M derived: sum of 3 quarters · filed 2013-03-18 | $18.29M derived: sum of 4 quarters · filed 2013-03-18 | $179.05M 10-Q · filed 2011-08-15 | |||||||||||
| 2011-03-31 | $4.37M 10-Q · filed 2012-05-10 | $8.81M derived: sum of 2 quarters · filed 2013-03-18 | $12.98M derived: sum of 3 quarters · filed 2013-03-18 | $16.60M derived: sum of 4 quarters · filed 2013-03-18 | ||||||||||||
| 2010-12-31 | $4.44M derived: 10-K 6 month − 10-Q 3 month · filed 2013-03-18 | $8.61M 10-K · filed 2013-03-18 | $12.23M derived: sum of 3 quarters · filed 2013-03-18 | |||||||||||||
| 2010-09-30 | $4.17M 10-Q · filed 2011-11-08 | $7.79M derived: sum of 2 quarters · filed 2011-11-08 | $10.63M 10-Q · filed 2011-11-08 | |||||||||||||
| 2010-06-30 | $3.62M 10-Q · filed 2011-08-15 | $6.46M 10-Q · filed 2011-08-15 | $12.66M 10-K · filed 2013-03-18 | |||||||||||||
| 2009-06-30 | $11.29M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |